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Objectives: Approximately 40% of community-acquired pneumonia (CAP) remains of
unknown etiology. To improve the rate of detection of the causative microbiologic
agent, the Binax NOW Streptococcus pneumoniae urinary antigen test (UAT) was
evaluated.
Design: In this prospective study, 67 adults with CAP were compared with 81 healthy
patients to determine sensitivity and specificity of the UAT and its role in improving
the etiologic diagnosis of CAP.
Results: An etiology could be found for 22 patients (33%) using conventional methods
(14 S. pneumoniae, sensitivity 64.3%, 1/81 positive UAT control urine samples,
specificity 98.8%). This proportion increased to 33 patients (49%) with the addition
of the urinary antigen test ( p = 0.039). Pneumococcal infection was diagnosed by the
UAT in 24% of our patients without an etiologic identification by conventional
methods.
Conclusions: Given its excellent specificity, this test can be considered an important
tool for detecting S. pneumoniae in CAPof unknown etiology, enabling the diagnosis of
pneumococcal pneumonia in a quarter of cases.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.* Corresponding author. Tel.: +41 32 9672111;
fax: +41 32 9672729.
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Diagnosis of community-acquired pneumonia (CAP)
relies on clinical criteria and on microbiological
results consisting of blood culture and culture ofes. Published by Elsevier Ltd. All rights reserved.
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stain.1 Many cases of CAP are of unknown etiology;
the sensitivity of blood culture is around 10—15%, and
that of sputum culture varies between 10 and 30%.
Even when invasive sampling techniques such as
broncho-alveolar lavage or transthoracic aspiration
are used, 40% of CAP remain of unknown etiology.2
Community-acquired pneumonia presents a chal-
lenge to the physician and its treatment is often
empirical. The need for a new rapid and specific test
for the detection of Streptococcus pneumoniae is
growing as pneumococcal pneumonia is considered
to be themain etiology due to cultivable bacteria. In
an era of increasing prevalence of antimicrobial
resistance, quick and unequivocal identification of
the etiology of pneumonia would considerably
improve patient management. The evaluation of a
new rapid urinary antigen test for the detection of S.
pneumoniae in adults suffering from CAP has been
carried out in previous studies.3—5 This rapid immu-
nochromatographic test detects the pneumococcal
C-polysaccharide antigen specific for the pneumo-
coccal cell wall and could facilitate the diagnosis of
S. pneumoniae pneumonia. We evaluated this new
test to determine its sensitivity, specificity and
contribution to the microbiologic diagnosis of CAP
of unknown cause in adults.Materials and methods
This was a prospective controlled study undertaken
at the La Chaux-de-Fonds Hospital, Switzerland.
Pneumonia group
The study was performed during one winter period
from October 1999 to May 2000. All patients aged
over 18 years presenting at hospital admission with
CAP were prospectively included in the study. Com-
munity-acquired pneumonia was defined by a new
infiltrate on chest X-ray associated with a leukocy-
tosis (>10  109/l) or leukopenia (<4  109/l), and
with one of the following: fever, dyspnea, cough,
chest pain or new sputum production.
Microbiological analysis for these patients
included blood cultures and culture of a sputum
sample. The presence of pathogens in blood or
sputum was assessed by conventional procedures.
Sputum Gram staining was performed on a purulent
portion of each sample. Samples were considered to
be of good quality when >25 polymorphonuclear
cells and <10 squamous cells were observed under
low-power (i.e., 100) magnification. Only good
quality sputum samples were accepted.An etiologic diagnosis of CAP was established in
accordance with the following conventional cri-
teria: recovery of a respiratory pathogen from cul-
ture of a specimen with normally sterile culture
results, and high yield of a respiratory pathogen
in a culture of a good-quality sputum sample with
a predominant morphotype on Gram stain. Uncon-
centrated urine samples were tested using the
immunochromatographic assay Binax NOW S. pneu-
moniae antigen (Portland, Maine, USA). This test
detects the C-polysaccharide antigen from the cell
wall of S. pneumoniae that is believed to be specific
for all pneumococcal serotypes.6 The test was per-
formed in accordance with the manufacturer’s
instructions. A swab was dipped into the urine
sample and then inserted into the test device. A
buffer solution was added, and the device was
closed, bringing the sample into contact with the
test strip. The test was read at 15 min and was
interpreted by noting the presence or absence of
visually detectable pink lines. A positive test result
was indicated by the detection of both sample and
control lines, and a negative result was indicated by
the detection of a control line only.
Aurinesamplewascollectedatadmissionbutcould
be accepted within the first 6 days following admis-
sion. Patients were excluded if they received an
antibioticmore than one day prior to hospitalization.
Control group
The control group consisted of random patients who
had urine sent for bacteriological culture for sus-
pected urinary tract infection. These urine samples
were collected during a period of low prevalence of
community-acquired pneumonia (August and Sep-
tember 2000). If the urinary antigen test was posi-
tive, the patient was medically evaluated to exclude
any history of pneumococcal infection or S. pneumo-
niae vaccination within 14 days prior to testing.
We also evaluated the place of the urinary anti-
gen test by calculating the likelihood ratio (LR).7 The
LR determines the performance of a test in a stan-
dardized fashion. It expresses the ratio of the prob-
ability that a given diagnostic test result would be
observed for a patient with the target disease versus
the probability for a patient without the disease. A
positive LR is calculated as follows: sensitivity/(1 —
specificity). A negative LR corresponds to: (1 — sen-
sitivity)/specificity. Tests with a positive LRof10 or
a negative LR of <0.1 are considered excellent.8 We
chose this approach to clearly and simply assess the
validity of this test by use of evidence-based clinical
microbiology principles and, in addition, to detect
more pneumococcal causes in community-acquired
pneumonia of unknown origin.
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Table 1 Microbiological tests and etiology of community-acquired pneumonia in 67 adult patients.
Total Sputum Blood culture Urinary test
Streptococcus pneumoniae 14 4a 11a 9
Haemophilus influenzae 3 3 0 0
Escherichia coli 3 3 0 0
Pasteurella multocida 1 1 0 0
Moraxella catarrhalis 1 1 0 0
Unknown 45 0 0 11
Total 67 (100%) 12 (18%) 11 (16%) 20 (30%)
a One patient had blood and sputum positive cultures.Results
A total of 67 patients were enrolled in the pneumo-
nia group; their mean age was 68 years (range: 34 to
91 years) and 29 (43%) were women. Forty-eight
(72%) had fever on admission and all of the patients
had a new infiltrate, mostly in the right lower lobe.
Leukocytosis was present in 63 (94%) patients. The
mean Pneumonia Severity Index9 was 106 (range:
30—231).
The control group consisted of 81 urine samples,
of which 25 were positive on culture (13 Escherichia
coli, six Staphylococcus spp., five other enterobac-
teriaceae and one Enterococcus faecalis); the mean
age of these patients was 64 years (range: 24 to 100
years) and 38 (47%) were women. Both groups were
comparable for age ( p = 0.3, Mann—Whitney test)
and sex ratio ( p = 0.74, Fisher’s exact test).
Twenty-two bacteria were identified from spu-
tum and/or blood cultures in 22 patients (33%) out of
67 from the pneumonia group (Table 1). No serolo-
gical test was performed. This explains the smaller
number of determined causes of pneumonia. Four-
teen pneumonia cases were attributed to S. pneu-
moniae according to sputum (four cases) and/or
blood culture results (11 cases). Of the 14 cases,
the urinary antigen test was positive in nine, giving a
sensitivity of 64.3% (Table 2). Of the 81 control urine
samples only one had a positive urinary antigen test
resulting in a high specificity of 98.8% (Table 2). The
positive LR was 53.6 and the negative LR 0.36.
The urinary antigen test was negative in all
pneumonia patients with a non-pneumococcal etiol-
ogy (eight cases), which confirms its high specificity,Table 2 Sensitivity and specificity of the S. pneumoniae u
Positive test
Pneumococcal pneumonia 9
Control without pneumonia 1
Total 10
Positive predictive
value: 90%and positive in 11 (24%) of the CAP patients with
negative blood or sputum cultures (45 cases). An
etiology was found for 22 patients (33%) without the
urinary antigen test and this proportion was
increased to 33 patients (49%) with the addition
of the urinary antigen test ( p = 0.039 Fisher’s
one-sided exact test) (Figure 1).Discussion
Streptococcus pneumoniae is the most common
cause of CAP but is undoubtedly under-diagnosed.2
Isolation of S. pneumoniae from blood is specific but
lacks sensitivity, while isolation of S. pneumoniae
from sputum may represent colonization. The urin-
ary antigen test is a major new tool for determining
the etiology of CAP in adults.
Contrary to the first published papers, the sensi-
tivity of the urinary antigen test in our study (64%) is
much lower than that found by Dominguez et al.3
and Burel et al.4 (between 78% and 86%) maybe
because the urine samples in our study could be
collected within the first 6 days compared to collec-
tions on the first day only in the other papers.3,4
Indeed, in patients with an initial positive urinary
antigen test, Murdoch and coworkers showed that
the test remained positive after 6 weeks in nearly
50% of them.10 Only Roso´n et al. found the same
limited sensitivity (66%) in their study as we did, but
the time period between admission and urine col-
lection is not stated in their paper.11 The specificity
was confirmed to be very high (>98%), comparable
to previous reports (>95%).3—5,12 This means that arinary antigen test.
Negative test Total
5 14 Sensitivity: 64.3%
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Figure 1 Improved rate of detection of causative agent
in CAP of unknown etiology.negative test could not rule out pneumococcal
pneumonia. On the other hand, a positive test
renders pneumococcal etiology for pneumonia
highly probable. This information is very useful
for those who work in areas where penicillin-resis-
tant S. pneumoniae is common because in cases with
a positive urinary antigen test it helps in the choice
of empiric antibiotic therapy.
Ruiz-Gonza`lez et al. showed that using transthor-
acic needle aspiration analysed by culture, capsular
antigen detection and PCR, to document most effi-
ciently the etiology of pneumonia cases, the number
of S. pneumoniae identified increased from 8.2% to
30%.2 Our study leads to similar results without the
need for an invasive sample using a simple and quick
method. Fourteen cases of S. pneumoniae were
identified by conventional methods and 11 addi-
tional cases solely by the urinary antigen test, which
represents an increase of 16% (21% to 37%) to reach a
final number of 25 cases of S. pneumoniae infection.
Compared with sputum and blood culture, the urin-
ary antigen test was the most efficient test giving an
etiology for almost one third of the community-
acquired pneumonia cases (30%) (Table 1).
With a rate of 11 positive blood cultures for
S. pneumoniae out of 20 CAP cases caused by
S. pneumoniae (positive urinary antigen tests)
(52%), our results are much higher than those com-
monly found in the literature (between 15% and
30%). Two reasons may explain this difference:
firstly, the published rates have been measured
for all patients with a community-acquired pneu-
monia. If one considers only those with a pneumo-
coccal pneumonia as a denominator, these rates are
probably much higher, as those found in our study
(52%). If we consider positive pneumococcal bacte-
remia for all patients included in our study, the rate
(11/67, 16%) remains in the expected range. Sec-
ondly, a previous study performed in the same
region, showed that fewer than 10% of patients
suffering from CAP were hospitalized.13 As thestudy population considered only hospitalized pa-
tients, we included the most severe cases (mean
Pneumonia Severity Index 106),which could explain
why we found more bacteremia.
Previous studies failed to find a causative agent in
about one-half of patients with CAP, and it has been
suggested that other causative agents remain to be
discovered.14—16 An alternative hypothesis is that
most of these patients have undetected pneumo-
coccal pneumonia.1,17 Our results are in accordance
with the latter explanation, because 24% of our
patients without an etiologic identification by con-
ventional methods had pneumococcal infection
detected by the urinary antigen test. These results
are in accordance with a recent published series
where about 25% of pneumonia with no pathogen
identified had a positive urinary antigen test.18
Roso´n et al. also showed that this urinary antigen
testing permitted early diagnosis of pneumococcal
pneumonia in 26% more patients than Gram stain-
ing.11
Unfortunately, this test cannot be used for enhan-
cing the detection rate of etiologies of community-
acquired pneumonia in children because of their
high percentage of S. pneumoniae nasopharyngeal
carriage, which is not the case in adults unless they
live with young children.19
This study has four main limitations: (1) As no
serological tests or virological cultures were per-
formed, the total number of determined causes of
pneumonia was low (33%). However, several other
investigators have reported a low rate of pathogen
isolation if no other tests than culture were per-
formed.20 (2) No bronchoscopy or other invasive
procedure has been done to prove the presence
of S. pneumoniae in patients with negative blood
and sputum cultures but with positive urinary anti-
gen test. In common practice, however, the use of
more invasive methods for sampling of lower-airway
secretions is impractical and not commonly per-
formed. (3) If patients had taken an antibiotic
before entering the study, they could have had
negative cultures while the urinary antigen test still
remained positive. (4) As the study was performed
during only one winter period the sample size was
rather small which could explain the significant
increase of etiologic diagnosis when using the urin-
ary antigen test. A large prospective study should
attempt to better define the place of this test in CAP
without a microbiological etiology.
This study confirms that the urinary antigen test
has a high specificity among patients with CAP and
significantly increases the diagnosis of a pneumo-
coccal origin beyond standard microbiological cul-
tures. The urinary antigen test raises the interesting
possibility that significantly more cases of CAP are
128 D. Genne´ et al.caused by S. pneumoniae than conventional tests
can currently confirm.Acknowledgments
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